McKesson Corporation (MCK) Stock Price, Fundamentals & Analysis

What MCK does

McKesson Corporation (MCK) is a US-based stock in the Healthcare sector, operating in the Medical Distribution industry. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products to retail pharmacies, hospitals, long-term care centres, clinics, and institutions. It also provides logistics and distribution services for manufacturers, consulting and outsourcing services, technology solutions for pharmacies, and gene therapy through InspiroGene, while helping solve medication access, affordability, and adherence challenges across the healthcare system.

Key numbers explained

• McKesson Corporation (MCK) trades at 880.5 USD per share, with a market capitalisation of 102.66B USD, placing it among the largest companies by total market value.
• The trailing P/E ratio of 23.6 shows how much investors pay for each dollar of the last twelve months' earnings; the forward P/E ratio of 17.4 uses expected future earnings and is typically read as a more forward-looking valuation.
• The dividend yield of 0.42% indicates the annual dividend as a percentage of the current share price, while the ex-dividend date is 1 Sept. 2026 and only 9% of trailing earnings are paid out as dividends.
• Beta of 0.31 suggests the stock has historically been less volatile than the broader market.
• Over the last 52 weeks, the price ranged from 715.31 to 999, and the price change over that period is 17.2%.
• Trailing 12-month revenue stands at 410.98 mld. USD, with year-over-year revenue growth of 7.7%, while profit margin is 1.1% and operating margin is 1.3%.
• The next earnings release is scheduled for 4 Nov. 2026.

Recent news

Recent headlines note that McKesson Corporation (MCK) is attracting investor attention and that the company has announced its second quarter fiscal 2027 earnings release date. Other stories in the feed discuss broader healthcare topics, including specialty care delivery expansion and comparisons of healthcare stocks such as AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?.

What to watch

Investors typically watch McKesson Corporation (MCK) alongside peers such as Pfizer (PFE) and other healthcare names like Humana (HUM) and UnitedHealth Group (UNH). Factors that can affect the stock include changes in drug pricing policy, healthcare regulation, payer mix, generic competition, supply chain dynamics, and broader movements in the S&P 500. Earnings reports, guidance updates, and shifts in distribution volumes or margins are also common catalysts for the sector.